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Background: The number of patients presenting with acute myocardial infarction (AMI) and being untreatable by
interventional cardiologists increased during the last years. Previous experience in emergency coronary artery
bypass grafting (CABG) in these patients spurred us towards a more liberal acceptance for surgery. Following a
prospective protocol, patients were operated on and further analysed.
Methods: Within a two year interval, 127 patients (38 female, age 68±12 years, EuroScore (ES) II 6.7±7.2%)
presenting with AMI (86 non-ST-elevated myocardial infarction (NSTEMI), 41 STEMI) were immediately accepted for
emergency CABG and operated on within six hours after cardiac catheterisation (77% three-vessel-disease, 47% left
main stem stenosis, 11% cardiogenic shock, 21% preoperative intraaortic balloon pump (IABP), left ventricular
ejection fraction 48±15%).
Results: 30-day-mortality was 6% (8 patients, 2 NSTEMI (2%) 6 STEMI (15%), p=0.014). Complete revascularisation could
be achieved in 80% of the patients using 2±1 grafts and 3±1 distal anastomoses. In total, 66% were supported by IABP,
extracorporal life support (ECLS) systems were implanted in two patients. Logistic regression analysis revealed the ES II
as an independent risk factor for mortality (p<0.001, HR 1.216, 95%-CI-Intervall 1.082-1.366).
Conclusions: Quo ad vitam, results of emergency CABG for patients presenting with NSTEMI can be compared with
those of elective revascularisation. Complete revascularisation obviously offers a clear benefit for the patients. Mortality
in patients presenting with STEMI and cardiogenic shock is substantially high. For these patients, other concepts
regarding timing of surgical revascularisation and bridging until surgery need to be taken into consideration.
Keywords: Myocardial infarction, Coronary artery bypass grafting, Emergency surgeryBackground
Multiple randomized studies have identified percutaneous
coronary intervention (PCI) as being superior to medical
thrombolysis in patients presenting with acute myocardial
infarction (AMI) [1]. As a consequence, coronary angio-
grams are increasingly performed, resulting in a higher
number of patients not suitable for PCI [2].
Nevertheless, primary coronary artery bypass grafting
(CABG) in patients with three-vessel-disease is performed* Correspondence: Bobylev.Dmitry@mh-hannover.de
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reproduction in any medium, provided the orin only 5% of all patients presenting with AMI and in
another 5% after primary PCI before discharge [3,4]. Similar
results are seen in patients presenting with cardiogenic
shock. In a recent study, only 3.5% of these patients
underwent CABG during hospital stay [5].
Initial results in the 1970s showed dismal outcome
for emergency CABG [6]. Within the last years, both
perioperative management and myocardial protection
improved significantly, leading to acceptable results of
emergency CABG, even in patients with cardiogenic
shock [7]. Due to our own experience on the one hand
and that of other centers on the other, emergency
CABG was not only considered as a rescue therapy
anymore [8]. Therefore, we prospectively evaluated theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.








Age (years) 68±12 68±12 69±12 0.5
Female 38 (30%) 25 (29%) 13 (31%) 0.7
BMI (kg/m2) 28±5 28±5 27±4 0.3
Hypertension 95 (74%) 68 (79%) 27 (64%) 0.4
Current or ex-smokers 38 (30%) 29 (34%) 9 (21%) 0.2
Hyperlipoproteinemia 62 (48%) 45 (52%) 17 (40%) 0.5
Diabetes 27 (21%) 23 (27%) 14 (33%) 0.3
EuroScore II (%) 6.7±7.2 5.6±5.9 9.1±8.9 0.023
Previous MI 18 (14%) 12 (14%) 6 (14%) 0.9
Left main stem stenosis 59 (47%) 38 (44%) 21 (50%) 0.4
Three-vessel-disease 98 (77%) 69 (80%) 29 (70%) 0.2
LV-EF (%) 48±15 52±14 40±15 0.001
CPR 9 (7%) 4 (5%) 5 (12%) 0.1
Cardiogenic shock 14 (11%) 8 (9%) 6 (14%) 0.07
IABP 27 (21%) 16 (19%) 11 (26%) 0.3
CK (U/L) 558±669 511±647 665±714 0.3
CK-MB (U/L) 71±90 64±72 87±118 0.2
CK/CK-MB-Index (%) 14±9 14±10 13±9 0.6
CK-MB≥100 (U/L) 24 (19%) 19 (22%) 5 (12%) 0.06
BMI body mass index, MI myocardial infarction, LV-EF left ventricular ejection
fraction, CPR cardio pulmonal resuscitation, IABP intra aortic balloon pump, CK
creatin kinase, CK-MB MB isoenzyme of CK.
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strategy in patients presenting with acute myocardial
infarction that were deemed untreatable or rejected by
the referring cardiologist.
Methods
This work was approved by the institutional review board
of Hannover Medical School. All patients gave informed
consent. The study was conducted at Hannover Medical
School.
Patients
Hannover Medical School is a tertiary care level I univer-
sity hospital with a 24h helipad performing approximately
1800 cardiac procedures per year. From January 2009 to
December 2010, 1333 patients underwent isolated CABG
at our institution. Out of these, 127 (9.5%) patients presented
with AMI (ST-segment elevation MI (STEMI) and non-
ST-segment elevation MI (NSTEMI)) and underwent
immediate CABG (less than six hours) after cardiac cath-
eterisation. Patients were transferred to our department
by ground or helicopter emergency service. Patients with
sole instable angina were excluded from the analysis.
In addition to the demographic data, the EuroScore (ES)
II was calculated for all patients. Patient’s demographics
and preoperative data are depicted in Table 1. All patients
were troponin positive. Troponin values are not presented
since unfortunately cut off levels and standard measuring
methods changed while the study was conducted.
No special platelet function analyses have been performed
in these patients.
Preoperative and anesthesia management
The team consisted of a senior consultant anaesthesiolo-
gist, a senior consultant cardiothoracic surgeon, a senior
resident and a cardiothoracic fellow. Additionally, an
experienced scrub nurse and a perfusionist trained in the
full spectrum of extracorporal support were available.
If not onsite, team members were available within 30
minutes at all hours.
All patients had been rejected for interventional
treatment by an experienced cardiologist of the referring
hospital or department. In selected cases, an interven-
tional cardiologist of our institution was consulted.
All patients were transferred to the operating room
immediately upon arrival. In cases of delay, patients
were transferred to the intensive care unit (ICU) and an
intraaortic balloon pump (IABP) was inserted using a
femoral access, according to the manufacturer’s suggestions.
Blood pressure levels were kept high using vasopressors
(e.g. norepinephrine) and the central venous saturation
was kept above 60%. Monitoring was performed via a
central venous line, an arterial line and a pulmonal arterial
catheter in all patients.Anesthesia was induced in a standard fashion; in
patients with cardiogenic shock anesthetization took place
in the operating theatre.
Surgical technique
The detailed surgical technique is described elsewhere
[8]. Briefly, after standard preparation surgery was performed
using cardiopulmonary bypass and cardiac arrest (Buckberg
cardioplegia) in most of the cases. A combination of left
internal thoracic artery (ITA) and saphenous vein grafts
was chosen for revascularisation whenever the patient was
stable, according to the surgeon’s preferences. A left atrial
catheter was obtained in all patients. An IABP was inserted
if there were no contraindications.
Postoperative management
Sedation was maintained until hemodynamic stabilisation
was achieved. IABP was no contraindication for extubation.
Blood transfusion and hemostatic therapy were adapted to
chest drain output and laboratory parameters, as well as
preoperative anticoagulation management. Patients that
had been loaded with two platelet inhibitors received units
of platelets after protamine administration in the majority
of cases.
Heparin and aspirin (100 mg/d) were administered for
anticoagulation within the first post-operative days. Later
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continued for at least six months according to current
guidelines [9].
Statistical analysis
Results are given as mean ± standard deviation or percent-
age. Statistical analysis for group comparison was performed
using the unpaired respectively paired t-test, the chi-square
or Fisher’s exact test. Forward stepwise logistic regression
analysis (likelihood ratio) was used to discriminate risk
factors of 30-day mortality. The Kaplan-Meier survival
estimate was used to analyse overall survival. Statistical
differences were determined using the log-rank test. Re-
ceiver operating characteristic (ROC) was plotted: the area
under the curve as well the sensitivity and specificity were
calculated. A p-value of <0.05 was deemed significant.
IBM SPSS Statistics (Vers. 20) software was used for
statistical analysis.
Results
Due to our previous experience and acceptance of this
special cohort of patients, we had an increasing caseload
of patients with AMI. Within this 2-year-interval, 127
patients were operated on. The number of patients not
referred for surgery by the treating cardiologist as well
as the detailed underlying reasons remain unclear, as well
as the individual time delay between onset of symptoms
and cardiac catheterisation.
Preoperative data
Patients were grouped according to etiology (NSTEMI/
STEMI), EuroScore II as well as impaired left ventricular
ejection fraction (LV-EF) (≤30%). The results of this
comparison are plotted in Figure 1. All patients had been















Figure 1 Patients were grouped according to Euroscore II (ES) and imtotal of 41 patients (32%) additionally had received 600
mg clopidogrel per os.
Intraoperative data
Intraoperative data are depicted in Table 2. Cardiopul-
monary bypass and moderate hypothermia (34°C) were
used in all patients with two or more vessel disease, in
the majority of cases with antegrade administration of
cold blood cardioplegia (Buckberg). On average, three
anastomoses were performed (in 58% as a combination of
an arterial graft and venous grafts) leading to a complete
revascularisation rate of 80%. During reperfusion, another
57 IABPs were inserted. An extracorporal life support
(ECLS) system was implanted in two patients.
Postoperative data
Most of the patients (70%) needed inotropic support
postoperatively. The index of cardiac markers decreased
significantly (p<0.001) within the first day after surgery. The
duration of IABP support was adapted to catecholomine
dosage as well as the trend of cardiac markers. One patient
of the STEMI group could not be weaned from IABP
support and underwent subsequent implantation of a
left ventricular assist device.
There was a slightly higher rate of re-exploration in the
STEMI-group which however did not reach statistical sig-
nificance. Receiving a loading dose of two platelet inhibi-
tors was not a risk factor for re-exploration (p=0.1).
Outcome
Temporary dialysis rate was low. Stroke rate was accept-
able given the fact that none of the patients underwent
evaluation of the carotid arteries preoperatively which is
performed in routine patients. In patients with previous
cardiopulmonary resuscitation (CPR) or that were intubatedII ≥ 10% ES ≥ 15%
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paired left ventricular ejection fraction (LV-EF).








On Pump 120 (94%) 81 (94%) 39 (95%) 0.8
CPB (min) 85±30 83±26 89±38 0.3
Cross-Clamp (min) 37±16 38±17 37±15 0.9
Mammarian graft 74 (58%) 52 (60%) 22 (54%) 0.2
Number of grafts 2±1 2±1 2±1 0.5
Number of anastomoses 3±1 3±1 3±1 0.6
Complete revascularisation 102 (80%) 68 (79%) 34 (83%) 0.7
IAPB intraoperative 57 (45%) 40 (47) 17 (41%) 0.6
IABP total 84 (66%) 56 (65%) 28 (68%) 0.6
ECLS 2 (2%) 1 (1%) 1 (2%) 0.6
IAPB duration (d) 2±2 1±1 2±3 0.1
Postoperativ inotropic
support
89 (70%) 59 (69%) 30 (73%) 0.8
CK/CK-MB-Index (%) 6 h 10±4 10±4 10±4 0.4
CK/CK-MB-Index (%) 24h 6±4 6±4 6±3 0.8
CK-MB≥100 (U/L) 6h 36 (28%) 19 (22%) 17 (62%) 0.02
CK-MB≥100 (U/L) 24h 20 (16%) 13 (15%) 7 (17%) 0.6
Respiratorory insuffiency 11 (9%) 6 (5%) 5 (12%) 0.3
Rethoracotomy 9 (7%) 5 (6%) 4 (10%) 0.4
ICU-stay (d) 5±6 4±4 5±8 0.2
CPB cardiopulmonary bypass, IABP intra aortic balloon pump, ECLS
extracorporal life support, CK creatin kinase, CK-MB MB isoenyzme of CK, ICU
intensive care unit.
Patients@risk
86 84 84 84 84 84 83


















Figure 2 Kaplan-Meier Survival function, subdivided into
NSTEMI and STEMI patients for the first 30 postoperative days.
Table 4 Regression analysis (30-day-mortality)
Factor p p (logistic regression)
Cardiogenic shock 0.043
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impossible (Table 3).
Survival
Comparison of hospital as well as 30-day-mortality rates
revealed significant differences between the NSTEMI
and STEMI group. The Kaplan-Meier curve showed a
significant better survival of the NSTEMI patients
(p=0.007) (Figure 2). Furthermore, mortality in patients
presented in cardiogenic shock preoperatively was
significantly increased compared to those without shock
(21% vs. 4%, p=0.043).
Risk factor analysis for 30-day-mortality
Patients that died significantly more often had presented








Dialysis (new) 3 (2%) 1 (1%) 2 (5%) 0.2
Stroke 5 (4%) 5 (6%) 0 0.1
Hospital-mortality 7 (6%) 1 (1%) 6 (15%) 0.005
30-day-mortality 8 (6%) 2 (2%) 6 (15%) 0.014of IABP support preoperatively. LV-EF (29±17% vs.
50±14%) was reduced and EuroScore II values were
increased (18±14% vs. 6±6%) (Table 4). Furthermore,
CK-MB levels were more often >100 U six and 24
hours after revascularisation. These factors were used for
a logistic regression model. The EuroScore II was the only
independent predictor of mortality.
ROC analysis for the EuroScore II
A ROC curve was plotted for the EuroScore II (area
under the curve 0.778) (Figure 3). The EuroScore II had
100% sensitivity (for an estimated risk up to 2.84%);
specificity was 60%.
Discussion
Mortality of patients with AMI undergoing emergency
CABG could be reduced within the past years [2].
According to our own experience on the one hand and
that of others on the other, survival could be improved
using a prospective treatment protocol [10]. ThereforeIABP preoperative 0.064
LV-EF 0.002
STEMI 0.014
CK-MB≥100 (U/L) 6h <0.001
CK-MB≥100 (U/L) 24h 0.054
EuroScore II 0.04 p<0.001, HR 1.216,
95-CI-Intervall 1.082-1.366
IABP intra aortic balloon pump, LV-EF left ventricular ejection fraction, STEMI









Figure 3 Receiver operating characteristics (ROC) curve for the
EuroScore II.
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presenting with AMI [8]. Patients were accepted imme-
diately from the referring cardiologist and were trans-
ferred to our emergency department. The sheath in the
groin for cardiac catheterisation was kept in place for
later on introduction of an IABP, if necessary. The
patients were triaged by a board certified cardiothoracic
surgeon and transferred immediately to the operating
room. In cases of lacking diagnostics or shortage of
capacity, the patient was transferred to the ICU and
bridged with an IABP. In these cases, surgery was
performed within the next 60 minutes.
Using this concept, the overall mortality rate was 6%.
The mortality rate for NSTEMI patients was 2% which
equals the general mortality rate for CABG in Germany
in 2011 (2.9%) [11]. Mortality in the STEMI group (15%)
was significantly increased in comparison to the NSTEMI
patients, but lower than in our previous experience and
that of others [7,8,12]. Even after failed PCI in patients
with AMI and shock, CABG significantly improved sur-
vival [7]. In this study, the mortality rate could be reduced
from 40.9 to 20.5% in the propensity score analysis. In the
recent shock II trial, Thiele and co-workers performed a
prospective study on the role of IABP usage for survival.
Mortality rate was high in both groups. CABG was only
performed in 3.5% of the patients despite the fact that more
than 50% of the patients had a three-vessel disease [5].
Optimal timing is an important issue in this context. In a
current analysis, Caceres and co-workers tried to elucidate
the optimal timing of coronary artery bypass grafting in
acute myocardial infarction [2]. They concluded that in
general delaying CABG especially in hemodynamicallystable patients cannot be considered as a standard of care
anymore.
Excellent results were achieved by Alexiou and co-
workers [12]. Mortality rate was less than 10% for NSTEMI
as well as STEMI patients and immediate revascularisation
was recommended. These results are to be interpreted in
the context of an analysis from Assmann and associates
[13]. In their retrospective analysis they identified early
CABG as a risk factor for mortality and recommended at
least a three-day waiting period. The rate of IABP support
in patients that were revascularised immediately was low
(10.5%) and the number of patients that died during the
waiting interval remains unclear. This results in a decrease
of the calculated mortality rate of patients that were
revascularised later on [2].
According to current European guidelines, CABG is
recommended three to seven days after AMI [14]. This
recommendation is based on a retrospective study [15].
However, in patients with failed PCI or fibrinolysis and
persistent hemodynamic instability, a IC recommendation
is given for emergency surgery.
The EuroScore II might be useful to identify patients
with a high operative risk in the future [16]. However,
according to the data available so far ES II should not be
used to reject patients since current studies revealed an
unsatisfactory sensitivity and specificity. Furthermore,
especially for these high risk patients no alternative
revascularisation strategy exists.
The preoperative anticoagulation regime may have a fur-
ther impact on surgical revascularisation. In 1998 clopi-
dogrel entered the market leading to a decreasing number
of studies addressing the issue of emergency CABG [2].
With the introduction of Ticagrelor and Prasugrel, two
reversibly binding platelet inhibitors emerged in the recent
year and may lead to further changes. For example, if
Ticagrelor is stopped less than one day before surgery,
65.5% of the patients had CABG-related life threatening/
fatal bleeding [17]. So far, clopidogrel was no contraindica-
tion for immediate revascularisation, but the recovery time
of platelets after loading dose administration of prasugrel is
up to nine days [18]. This may have an impact on further
timing strategies.
Besides timing, the operative technique of revascula-
risation is controversially discussed. Rastan and co-workers
recommended beating heart technique for patients pre-
senting with acute coronary syndrome (including instable
angina) [19]. However, they had a significantly lower rate
of incomplete revascularisation in the beating heart group
and short reperfusion times in the crossclamp group; the
majority of patients received crystalloid instead of cold
blood cardioplegia [20].
In our experience, reperfusion of at least 30 minutes is
important in this patient cohort. This has been shown
earlier in experimental as well as in clinical setups [21,22].
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increased. However, the ITA was not used in patients
presenting in cardiogenic shock or with high doses of
vasopressors after induction of anesthesia, due to the
fear of vasospasms occurring postoperatively [22,23].
In patients presenting in cardiogenic shock or with
reduced LV-EF, the implantation of an extracorporeal life
support system (ECLS) must be taken into consideration
to achieve a longer reperfusion time and additional
ventricular unloading [21,24,25]. If end-organ functions
recover but weaning is impossible due to impaired LV-
function, implantation of an left ventricular assist device
is a feasible option, if no contraindication exists [26].Limitations
The number of patients presented is too low to establish
an accurate estimation of the operative risk for this high
risk patient cohort. The number of patients not referred
for emergency revascularisation, especially those in car-
diogenic shock, remains unclear.
There is no control group of patients that receive
CABG after a waiting period, since in this two year
interval all patients were operated on immediately. The
same is true for patients receiving a PCI of the culprit
lesion and CABG later on. Additionally, there is also no
fitting control group given in current literature. Follow-up
beyond 30 day is lacking so far.Conclusions
Immediate surgical revascularisation of patients presenting
with acute AMI is feasible and leads to excellent results in
NSTEMI patients. Mortality in STEMI patients, especially
in those presenting in cardiogenic shock and or with
impaired LV-function, is substantially high. For these
patients, other timing or revascularisation strategies
have to be implemented in the future. One option might
be a more liberal implantation of an ECLS system in
selected patients allowing myocardial recovery due to
prolonged reperfusion and ventricular unloading. The
same approach can be taken into consideration if myocar-
dial markers do not decrease within the first 24 hours
after surgery. Treating the culprit lesion only under ECLS
support or ECLS standby, followed by CABG after stabil-
isation, might be another option. This has to be elucidated
in further studies.
Nevertheless, not only treating the culprit lesion but
achieving a complete revascularisation offers a clear
advantage for the patient. This might be true especially
for patients with three-vessel-disease and/or left main
stem stenosis. Feasibility of immediate revascularisation
of patients that have received a loading dose of novel,
reversibly binding platelet inhibitor, has to be elucidate
in further studies.Abbreviations
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